nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP1A2—Progesterone—uterine cancer	0.107	0.317	CbGbCtD
Rifabutin—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0849	0.251	CbGbCtD
Rifabutin—CYP3A4—Progesterone—uterine cancer	0.0563	0.166	CbGbCtD
Rifabutin—CYP1A2—Etoposide—uterine cancer	0.0481	0.142	CbGbCtD
Rifabutin—HSP90B1—oviduct—uterine cancer	0.0292	0.129	CbGeAlD
Rifabutin—CYP3A4—Etoposide—uterine cancer	0.0252	0.0743	CbGbCtD
Rifabutin—HSP90AA1—oviduct—uterine cancer	0.0214	0.0945	CbGeAlD
Rifabutin—CYP3A4—Doxorubicin—uterine cancer	0.0172	0.0507	CbGbCtD
Rifabutin—HSP90B1—exocrine gland—uterine cancer	0.0169	0.0746	CbGeAlD
Rifabutin—HSP90AA1—exocrine gland—uterine cancer	0.0123	0.0546	CbGeAlD
Rifabutin—HSP90B1—myometrium—uterine cancer	0.00936	0.0414	CbGeAlD
Rifabutin—HSP90B1—epithelium—uterine cancer	0.00734	0.0325	CbGeAlD
Rifabutin—HSP90B1—uterine cervix—uterine cancer	0.00728	0.0322	CbGeAlD
Rifabutin—HSP90B1—smooth muscle tissue—uterine cancer	0.00708	0.0313	CbGeAlD
Rifabutin—HSP90B1—decidua—uterine cancer	0.00694	0.0307	CbGeAlD
Rifabutin—HSP90AA1—myometrium—uterine cancer	0.00684	0.0302	CbGeAlD
Rifabutin—HSP90B1—renal system—uterine cancer	0.00681	0.0301	CbGeAlD
Rifabutin—HSP90B1—endometrium—uterine cancer	0.00659	0.0291	CbGeAlD
Rifabutin—HSP90B1—mammalian vulva—uterine cancer	0.00637	0.0282	CbGeAlD
Rifabutin—HSP90B1—uterus—uterine cancer	0.00607	0.0268	CbGeAlD
Rifabutin—HSP90B1—female reproductive system—uterine cancer	0.00546	0.0241	CbGeAlD
Rifabutin—HSP90AA1—epithelium—uterine cancer	0.00537	0.0237	CbGeAlD
Rifabutin—HSP90AA1—uterine cervix—uterine cancer	0.00532	0.0235	CbGeAlD
Rifabutin—HSP90AA1—smooth muscle tissue—uterine cancer	0.00517	0.0229	CbGeAlD
Rifabutin—HSP90AA1—decidua—uterine cancer	0.00507	0.0224	CbGeAlD
Rifabutin—HSP90AA1—renal system—uterine cancer	0.00498	0.022	CbGeAlD
Rifabutin—HSP90B1—female gonad—uterine cancer	0.00496	0.0219	CbGeAlD
Rifabutin—HSP90B1—vagina—uterine cancer	0.00493	0.0218	CbGeAlD
Rifabutin—HSP90AA1—endometrium—uterine cancer	0.00482	0.0213	CbGeAlD
Rifabutin—HSP90AA1—mammalian vulva—uterine cancer	0.00466	0.0206	CbGeAlD
Rifabutin—HSP90AA1—uterus—uterine cancer	0.00444	0.0196	CbGeAlD
Rifabutin—HSP90AA1—female reproductive system—uterine cancer	0.00399	0.0176	CbGeAlD
Rifabutin—HSP90AA1—female gonad—uterine cancer	0.00363	0.016	CbGeAlD
Rifabutin—HSP90AA1—vagina—uterine cancer	0.00361	0.0159	CbGeAlD
Rifabutin—HSP90B1—lymph node—uterine cancer	0.00319	0.0141	CbGeAlD
Rifabutin—HSP90AA1—lymph node—uterine cancer	0.00233	0.0103	CbGeAlD
Rifabutin—CYP1A2—renal system—uterine cancer	0.00161	0.00712	CbGeAlD
Rifabutin—Chest discomfort—Etoposide—uterine cancer	0.0016	0.00816	CcSEcCtD
Rifabutin—Skin discolouration—Etoposide—uterine cancer	0.00157	0.008	CcSEcCtD
Rifabutin—Lymphopenia—Epirubicin—uterine cancer	0.00155	0.00791	CcSEcCtD
Rifabutin—Bronchospasm—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.0079	CcSEcCtD
Rifabutin—Jaundice—Progesterone—uterine cancer	0.00151	0.0077	CcSEcCtD
Rifabutin—Myositis—Doxorubicin—uterine cancer	0.0015	0.00764	CcSEcCtD
Rifabutin—Body temperature increased—Carboplatin—uterine cancer	0.00149	0.00758	CcSEcCtD
Rifabutin—Hepatobiliary disease—Progesterone—uterine cancer	0.00147	0.00747	CcSEcCtD
Rifabutin—Lymphopenia—Doxorubicin—uterine cancer	0.00144	0.00732	CcSEcCtD
Rifabutin—Phosphatase alkaline increased—Etoposide—uterine cancer	0.00142	0.00722	CcSEcCtD
Rifabutin—Hepatitis—Progesterone—uterine cancer	0.00139	0.00709	CcSEcCtD
Rifabutin—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.00698	CcSEcCtD
Rifabutin—Connective tissue disorder—Progesterone—uterine cancer	0.00137	0.00697	CcSEcCtD
Rifabutin—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00677	CcSEcCtD
Rifabutin—Eye disorder—Progesterone—uterine cancer	0.0013	0.00663	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Dactinomycin—uterine cancer	0.00128	0.00652	CcSEcCtD
Rifabutin—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00643	CcSEcCtD
Rifabutin—Immune system disorder—Progesterone—uterine cancer	0.00126	0.00641	CcSEcCtD
Rifabutin—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00631	CcSEcCtD
Rifabutin—Flatulence—Progesterone—uterine cancer	0.00119	0.00608	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Etoposide—uterine cancer	0.00118	0.00603	CcSEcCtD
Rifabutin—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00601	CcSEcCtD
Rifabutin—Pancytopenia—Dactinomycin—uterine cancer	0.00117	0.00595	CcSEcCtD
Rifabutin—CYP3A4—renal system—uterine cancer	0.00117	0.00515	CbGeAlD
Rifabutin—Neutropenia—Dactinomycin—uterine cancer	0.00115	0.00586	CcSEcCtD
Rifabutin—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.0058	CcSEcCtD
Rifabutin—Anaemia—Progesterone—uterine cancer	0.00112	0.00571	CcSEcCtD
Rifabutin—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00551	CcSEcCtD
Rifabutin—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00548	CcSEcCtD
Rifabutin—Convulsion—Progesterone—uterine cancer	0.00105	0.00535	CcSEcCtD
Rifabutin—Arthralgia—Progesterone—uterine cancer	0.00103	0.00526	CcSEcCtD
Rifabutin—Chest pain—Progesterone—uterine cancer	0.00103	0.00526	CcSEcCtD
Rifabutin—Myalgia—Progesterone—uterine cancer	0.00103	0.00526	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00102	0.00522	CcSEcCtD
Rifabutin—Agranulocytosis—Dactinomycin—uterine cancer	0.00102	0.00521	CcSEcCtD
Rifabutin—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00517	CcSEcCtD
Rifabutin—Confusional state—Progesterone—uterine cancer	0.000997	0.00508	CcSEcCtD
Rifabutin—Hepatitis—Dactinomycin—uterine cancer	0.000984	0.00501	CcSEcCtD
Rifabutin—Shock—Progesterone—uterine cancer	0.000973	0.00496	CcSEcCtD
Rifabutin—Skin disorder—Progesterone—uterine cancer	0.000961	0.00489	CcSEcCtD
Rifabutin—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000951	0.00485	CcSEcCtD
Rifabutin—Anorexia—Progesterone—uterine cancer	0.000943	0.0048	CcSEcCtD
Rifabutin—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000935	0.00476	CcSEcCtD
Rifabutin—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000935	0.00476	CcSEcCtD
Rifabutin—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000935	0.00476	CcSEcCtD
Rifabutin—CYP3A4—female reproductive system—uterine cancer	0.000933	0.00413	CbGeAlD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000928	0.00473	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Etoposide—uterine cancer	0.000908	0.00462	CcSEcCtD
Rifabutin—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000904	0.0046	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000901	0.00459	CcSEcCtD
Rifabutin—Insomnia—Progesterone—uterine cancer	0.000895	0.00456	CcSEcCtD
Rifabutin—Paraesthesia—Progesterone—uterine cancer	0.000888	0.00452	CcSEcCtD
Rifabutin—Dyspnoea—Progesterone—uterine cancer	0.000882	0.00449	CcSEcCtD
Rifabutin—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000882	0.00449	CcSEcCtD
Rifabutin—Skin discolouration—Epirubicin—uterine cancer	0.00088	0.00448	CcSEcCtD
Rifabutin—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000877	0.00447	CcSEcCtD
Rifabutin—Bronchospasm—Etoposide—uterine cancer	0.000875	0.00446	CcSEcCtD
Rifabutin—Dyspepsia—Progesterone—uterine cancer	0.000871	0.00443	CcSEcCtD
Rifabutin—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00087	0.00443	CcSEcCtD
Rifabutin—Decreased appetite—Progesterone—uterine cancer	0.00086	0.00438	CcSEcCtD
Rifabutin—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000854	0.00435	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Progesterone—uterine cancer	0.000854	0.00435	CcSEcCtD
Rifabutin—Pain—Progesterone—uterine cancer	0.000846	0.00431	CcSEcCtD
Rifabutin—Pancytopenia—Etoposide—uterine cancer	0.000845	0.0043	CcSEcCtD
Rifabutin—Blood bilirubin increased—Epirubicin—uterine cancer	0.00084	0.00428	CcSEcCtD
Rifabutin—Neutropenia—Etoposide—uterine cancer	0.000832	0.00424	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000817	0.00416	CcSEcCtD
Rifabutin—Feeling abnormal—Progesterone—uterine cancer	0.000815	0.00415	CcSEcCtD
Rifabutin—Skin discolouration—Doxorubicin—uterine cancer	0.000814	0.00415	CcSEcCtD
Rifabutin—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000811	0.00413	CcSEcCtD
Rifabutin—Gastrointestinal pain—Progesterone—uterine cancer	0.000809	0.00412	CcSEcCtD
Rifabutin—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000805	0.0041	CcSEcCtD
Rifabutin—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000799	0.00407	CcSEcCtD
Rifabutin—Phosphatase alkaline increased—Epirubicin—uterine cancer	0.000795	0.00405	CcSEcCtD
Rifabutin—Anaemia—Dactinomycin—uterine cancer	0.000792	0.00403	CcSEcCtD
Rifabutin—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000789	0.00402	CcSEcCtD
Rifabutin—Abdominal pain—Progesterone—uterine cancer	0.000782	0.00398	CcSEcCtD
Rifabutin—Body temperature increased—Progesterone—uterine cancer	0.000782	0.00398	CcSEcCtD
Rifabutin—Eructation—Epirubicin—uterine cancer	0.000781	0.00398	CcSEcCtD
Rifabutin—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000779	0.00397	CcSEcCtD
Rifabutin—Blood bilirubin increased—Doxorubicin—uterine cancer	0.000778	0.00396	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000774	0.00394	CcSEcCtD
Rifabutin—Jaundice—Etoposide—uterine cancer	0.000773	0.00394	CcSEcCtD
Rifabutin—Leukopenia—Dactinomycin—uterine cancer	0.000767	0.00391	CcSEcCtD
Rifabutin—Hepatobiliary disease—Etoposide—uterine cancer	0.00075	0.00382	CcSEcCtD
Rifabutin—Agranulocytosis—Etoposide—uterine cancer	0.00074	0.00377	CcSEcCtD
Rifabutin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000739	0.00376	CcSEcCtD
Rifabutin—Phosphatase alkaline increased—Doxorubicin—uterine cancer	0.000736	0.00375	CcSEcCtD
Rifabutin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000733	0.00373	CcSEcCtD
Rifabutin—Myalgia—Dactinomycin—uterine cancer	0.000729	0.00371	CcSEcCtD
Rifabutin—Hypersensitivity—Progesterone—uterine cancer	0.000729	0.00371	CcSEcCtD
Rifabutin—Eructation—Doxorubicin—uterine cancer	0.000723	0.00368	CcSEcCtD
Rifabutin—Asthenia—Progesterone—uterine cancer	0.00071	0.00361	CcSEcCtD
Rifabutin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000708	0.00361	CcSEcCtD
Rifabutin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000708	0.00361	CcSEcCtD
Rifabutin—Pruritus—Progesterone—uterine cancer	0.0007	0.00356	CcSEcCtD
Rifabutin—Thrombocytopenia—Dactinomycin—uterine cancer	0.000684	0.00349	CcSEcCtD
Rifabutin—Diarrhoea—Progesterone—uterine cancer	0.000677	0.00345	CcSEcCtD
Rifabutin—Anorexia—Dactinomycin—uterine cancer	0.000666	0.00339	CcSEcCtD
Rifabutin—Eye disorder—Etoposide—uterine cancer	0.000665	0.00339	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.000663	0.00338	CcSEcCtD
Rifabutin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00066	0.00336	CcSEcCtD
Rifabutin—Immune system disorder—Etoposide—uterine cancer	0.000643	0.00328	CcSEcCtD
Rifabutin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000643	0.00328	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000637	0.00324	CcSEcCtD
Rifabutin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000634	0.00323	CcSEcCtD
Rifabutin—Vomiting—Progesterone—uterine cancer	0.000629	0.0032	CcSEcCtD
Rifabutin—Rash—Progesterone—uterine cancer	0.000624	0.00318	CcSEcCtD
Rifabutin—Dermatitis—Progesterone—uterine cancer	0.000623	0.00317	CcSEcCtD
Rifabutin—Headache—Progesterone—uterine cancer	0.00062	0.00316	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000614	0.00313	CcSEcCtD
Rifabutin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000613	0.00312	CcSEcCtD
Rifabutin—Decreased appetite—Dactinomycin—uterine cancer	0.000608	0.0031	CcSEcCtD
Rifabutin—Dysgeusia—Etoposide—uterine cancer	0.000607	0.00309	CcSEcCtD
Rifabutin—Pain—Dactinomycin—uterine cancer	0.000598	0.00305	CcSEcCtD
Rifabutin—Nausea—Progesterone—uterine cancer	0.000587	0.00299	CcSEcCtD
Rifabutin—Feeling abnormal—Dactinomycin—uterine cancer	0.000576	0.00293	CcSEcCtD
Rifabutin—Anaemia—Etoposide—uterine cancer	0.000573	0.00292	CcSEcCtD
Rifabutin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000572	0.00291	CcSEcCtD
Rifabutin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00057	0.0029	CcSEcCtD
Rifabutin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000565	0.00288	CcSEcCtD
Rifabutin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000565	0.00288	CcSEcCtD
Rifabutin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000561	0.00286	CcSEcCtD
Rifabutin—Leukopenia—Etoposide—uterine cancer	0.000555	0.00283	CcSEcCtD
Rifabutin—Abdominal pain—Dactinomycin—uterine cancer	0.000553	0.00282	CcSEcCtD
Rifabutin—Body temperature increased—Dactinomycin—uterine cancer	0.000553	0.00282	CcSEcCtD
Rifabutin—Convulsion—Etoposide—uterine cancer	0.000537	0.00274	CcSEcCtD
Rifabutin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000532	0.00271	CcSEcCtD
Rifabutin—Chest pain—Etoposide—uterine cancer	0.000528	0.00269	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000524	0.00267	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.00052	0.00265	CcSEcCtD
Rifabutin—Hypersensitivity—Dactinomycin—uterine cancer	0.000515	0.00262	CcSEcCtD
Rifabutin—Confusional state—Etoposide—uterine cancer	0.00051	0.0026	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000509	0.00259	CcSEcCtD
Rifabutin—Asthenia—Dactinomycin—uterine cancer	0.000502	0.00255	CcSEcCtD
Rifabutin—Thrombocytopenia—Etoposide—uterine cancer	0.000495	0.00252	CcSEcCtD
Rifabutin—Eosinophilia—Epirubicin—uterine cancer	0.000494	0.00252	CcSEcCtD
Rifabutin—Skin disorder—Etoposide—uterine cancer	0.000491	0.0025	CcSEcCtD
Rifabutin—Anorexia—Etoposide—uterine cancer	0.000482	0.00246	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000481	0.00245	CcSEcCtD
Rifabutin—Diarrhoea—Dactinomycin—uterine cancer	0.000478	0.00244	CcSEcCtD
Rifabutin—Pancytopenia—Epirubicin—uterine cancer	0.000474	0.00241	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000471	0.0024	CcSEcCtD
Rifabutin—Neutropenia—Epirubicin—uterine cancer	0.000466	0.00238	CcSEcCtD
Rifabutin—Eosinophilia—Doxorubicin—uterine cancer	0.000457	0.00233	CcSEcCtD
Rifabutin—Paraesthesia—Etoposide—uterine cancer	0.000454	0.00231	CcSEcCtD
Rifabutin—Dyspnoea—Etoposide—uterine cancer	0.000451	0.0023	CcSEcCtD
Rifabutin—Vomiting—Dactinomycin—uterine cancer	0.000444	0.00226	CcSEcCtD
Rifabutin—Rash—Dactinomycin—uterine cancer	0.000441	0.00225	CcSEcCtD
Rifabutin—Decreased appetite—Etoposide—uterine cancer	0.00044	0.00224	CcSEcCtD
Rifabutin—Pancytopenia—Doxorubicin—uterine cancer	0.000438	0.00223	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Etoposide—uterine cancer	0.000437	0.00223	CcSEcCtD
Rifabutin—Jaundice—Epirubicin—uterine cancer	0.000433	0.00221	CcSEcCtD
Rifabutin—Pain—Etoposide—uterine cancer	0.000433	0.0022	CcSEcCtD
Rifabutin—Neutropenia—Doxorubicin—uterine cancer	0.000431	0.0022	CcSEcCtD
Rifabutin—Hepatobiliary disease—Epirubicin—uterine cancer	0.000421	0.00214	CcSEcCtD
Rifabutin—Feeling abnormal—Etoposide—uterine cancer	0.000417	0.00212	CcSEcCtD
Rifabutin—Nausea—Dactinomycin—uterine cancer	0.000415	0.00212	CcSEcCtD
Rifabutin—Agranulocytosis—Epirubicin—uterine cancer	0.000415	0.00211	CcSEcCtD
Rifabutin—Gastrointestinal pain—Etoposide—uterine cancer	0.000414	0.00211	CcSEcCtD
Rifabutin—Jaundice—Doxorubicin—uterine cancer	0.000401	0.00204	CcSEcCtD
Rifabutin—Body temperature increased—Etoposide—uterine cancer	0.0004	0.00204	CcSEcCtD
Rifabutin—Abdominal pain—Etoposide—uterine cancer	0.0004	0.00204	CcSEcCtD
Rifabutin—Hepatitis—Epirubicin—uterine cancer	0.000399	0.00203	CcSEcCtD
Rifabutin—Connective tissue disorder—Epirubicin—uterine cancer	0.000392	0.002	CcSEcCtD
Rifabutin—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000389	0.00198	CcSEcCtD
Rifabutin—Agranulocytosis—Doxorubicin—uterine cancer	0.000384	0.00196	CcSEcCtD
Rifabutin—Eye disorder—Epirubicin—uterine cancer	0.000373	0.0019	CcSEcCtD
Rifabutin—Hypersensitivity—Etoposide—uterine cancer	0.000373	0.0019	CcSEcCtD
Rifabutin—Hepatitis—Doxorubicin—uterine cancer	0.000369	0.00188	CcSEcCtD
Rifabutin—Asthenia—Etoposide—uterine cancer	0.000363	0.00185	CcSEcCtD
Rifabutin—Connective tissue disorder—Doxorubicin—uterine cancer	0.000363	0.00185	CcSEcCtD
Rifabutin—Immune system disorder—Epirubicin—uterine cancer	0.000361	0.00184	CcSEcCtD
Rifabutin—Pruritus—Etoposide—uterine cancer	0.000358	0.00182	CcSEcCtD
Rifabutin—Diarrhoea—Etoposide—uterine cancer	0.000346	0.00176	CcSEcCtD
Rifabutin—Eye disorder—Doxorubicin—uterine cancer	0.000345	0.00176	CcSEcCtD
Rifabutin—Flatulence—Epirubicin—uterine cancer	0.000342	0.00174	CcSEcCtD
Rifabutin—Dysgeusia—Epirubicin—uterine cancer	0.00034	0.00173	CcSEcCtD
Rifabutin—Immune system disorder—Doxorubicin—uterine cancer	0.000334	0.0017	CcSEcCtD
Rifabutin—Vomiting—Etoposide—uterine cancer	0.000322	0.00164	CcSEcCtD
Rifabutin—Anaemia—Epirubicin—uterine cancer	0.000321	0.00164	CcSEcCtD
Rifabutin—Rash—Etoposide—uterine cancer	0.000319	0.00163	CcSEcCtD
Rifabutin—Dermatitis—Etoposide—uterine cancer	0.000319	0.00162	CcSEcCtD
Rifabutin—Headache—Etoposide—uterine cancer	0.000317	0.00161	CcSEcCtD
Rifabutin—Flatulence—Doxorubicin—uterine cancer	0.000317	0.00161	CcSEcCtD
Rifabutin—Dysgeusia—Doxorubicin—uterine cancer	0.000315	0.0016	CcSEcCtD
Rifabutin—Leukopenia—Epirubicin—uterine cancer	0.000311	0.00158	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—CDKN1B—uterine cancer	0.000309	0.00129	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	0.000307	0.00129	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—ERBB2—uterine cancer	0.000306	0.00129	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—KRAS—uterine cancer	0.000306	0.00128	CbGpPWpGaD
Rifabutin—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000304	0.00127	CbGpPWpGaD
Rifabutin—Convulsion—Epirubicin—uterine cancer	0.000301	0.00153	CcSEcCtD
Rifabutin—Nausea—Etoposide—uterine cancer	0.000301	0.00153	CcSEcCtD
Rifabutin—Anaemia—Doxorubicin—uterine cancer	0.000297	0.00151	CcSEcCtD
Rifabutin—Myalgia—Epirubicin—uterine cancer	0.000296	0.00151	CcSEcCtD
Rifabutin—Chest pain—Epirubicin—uterine cancer	0.000296	0.00151	CcSEcCtD
Rifabutin—Arthralgia—Epirubicin—uterine cancer	0.000296	0.00151	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000294	0.0015	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—HRAS—uterine cancer	0.000293	0.00123	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—KRAS—uterine cancer	0.000288	0.00121	CbGpPWpGaD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—HRAS—uterine cancer	0.000288	0.00121	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—FGFR2—uterine cancer	0.000288	0.00121	CbGpPWpGaD
Rifabutin—Leukopenia—Doxorubicin—uterine cancer	0.000288	0.00147	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—CDKN1B—uterine cancer	0.000288	0.00121	CbGpPWpGaD
Rifabutin—Confusional state—Epirubicin—uterine cancer	0.000286	0.00146	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—PTEN—uterine cancer	0.000284	0.00119	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—CDKN1B—uterine cancer	0.000284	0.00119	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—AKT1—uterine cancer	0.000284	0.00119	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—PIK3CA—uterine cancer	0.000281	0.00118	CbGpPWpGaD
Rifabutin—Shock—Epirubicin—uterine cancer	0.000279	0.00142	CcSEcCtD
Rifabutin—Convulsion—Doxorubicin—uterine cancer	0.000279	0.00142	CcSEcCtD
Rifabutin—Thrombocytopenia—Epirubicin—uterine cancer	0.000278	0.00141	CcSEcCtD
Rifabutin—Skin disorder—Epirubicin—uterine cancer	0.000275	0.0014	CcSEcCtD
Rifabutin—Chest pain—Doxorubicin—uterine cancer	0.000274	0.00139	CcSEcCtD
Rifabutin—Myalgia—Doxorubicin—uterine cancer	0.000274	0.00139	CcSEcCtD
Rifabutin—Arthralgia—Doxorubicin—uterine cancer	0.000274	0.00139	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000272	0.00138	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—CTNNB1—uterine cancer	0.000272	0.00114	CbGpPWpGaD
Rifabutin—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000271	0.00113	CbGpPWpGaD
Rifabutin—Anorexia—Epirubicin—uterine cancer	0.00027	0.00138	CcSEcCtD
Rifabutin—HSP90AA1—Disease—RNF43—uterine cancer	0.000269	0.00113	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—PIK3CA—uterine cancer	0.000265	0.00111	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—PTEN—uterine cancer	0.000265	0.00111	CbGpPWpGaD
Rifabutin—Confusional state—Doxorubicin—uterine cancer	0.000265	0.00135	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—MET—uterine cancer	0.000263	0.0011	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	0.000263	0.0011	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—PTEN—uterine cancer	0.000261	0.0011	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.00026	0.00109	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—HRAS—uterine cancer	0.00026	0.00109	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—AKT1—uterine cancer	0.000259	0.00109	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—AKT1—uterine cancer	0.000259	0.00109	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000258	0.00132	CcSEcCtD
Rifabutin—Shock—Doxorubicin—uterine cancer	0.000258	0.00132	CcSEcCtD
Rifabutin—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000258	0.00108	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—CXCL8—uterine cancer	0.000257	0.00108	CbGpPWpGaD
Rifabutin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000257	0.00131	CcSEcCtD
Rifabutin—Insomnia—Epirubicin—uterine cancer	0.000257	0.00131	CcSEcCtD
Rifabutin—Skin disorder—Doxorubicin—uterine cancer	0.000255	0.0013	CcSEcCtD
Rifabutin—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000255	0.00107	CbGpPWpGaD
Rifabutin—Paraesthesia—Epirubicin—uterine cancer	0.000255	0.0013	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—NRAS—uterine cancer	0.000254	0.00106	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—STAR—uterine cancer	0.000253	0.00106	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AKR1B1—uterine cancer	0.000253	0.00106	CbGpPWpGaD
Rifabutin—Dyspnoea—Epirubicin—uterine cancer	0.000253	0.00129	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—EP300—uterine cancer	0.000253	0.00106	CbGpPWpGaD
Rifabutin—Anorexia—Doxorubicin—uterine cancer	0.00025	0.00127	CcSEcCtD
Rifabutin—Dyspepsia—Epirubicin—uterine cancer	0.00025	0.00127	CcSEcCtD
Rifabutin—Decreased appetite—Epirubicin—uterine cancer	0.000247	0.00126	CcSEcCtD
Rifabutin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000245	0.00103	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—HRAS—uterine cancer	0.000245	0.00103	CbGpPWpGaD
Rifabutin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000245	0.00125	CcSEcCtD
Rifabutin—Pain—Epirubicin—uterine cancer	0.000243	0.00124	CcSEcCtD
Rifabutin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000242	0.00102	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000239	0.00122	CcSEcCtD
Rifabutin—HSP90B1—Metabolism of proteins—CTNNB1—uterine cancer	0.000237	0.000995	CbGpPWpGaD
Rifabutin—Insomnia—Doxorubicin—uterine cancer	0.000237	0.00121	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—CDKN2A—uterine cancer	0.000237	0.000994	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	0.000237	0.000993	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—NRAS—uterine cancer	0.000236	0.000991	CbGpPWpGaD
Rifabutin—Paraesthesia—Doxorubicin—uterine cancer	0.000236	0.0012	CcSEcCtD
Rifabutin—Dyspnoea—Doxorubicin—uterine cancer	0.000234	0.00119	CcSEcCtD
Rifabutin—Feeling abnormal—Epirubicin—uterine cancer	0.000234	0.00119	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—NRAS—uterine cancer	0.000233	0.000978	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN2B—uterine cancer	0.000232	0.000974	CbGpPWpGaD
Rifabutin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000232	0.00118	CcSEcCtD
Rifabutin—Dyspepsia—Doxorubicin—uterine cancer	0.000231	0.00118	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—AKT1—uterine cancer	0.000229	0.000962	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—SMAD3—uterine cancer	0.000229	0.000961	CbGpPWpGaD
Rifabutin—Decreased appetite—Doxorubicin—uterine cancer	0.000228	0.00116	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—AKR1B10—uterine cancer	0.000228	0.000954	CbGpPWpGaD
Rifabutin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000227	0.00115	CcSEcCtD
Rifabutin—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	0.000225	0.000944	CbGpPWpGaD
Rifabutin—Pain—Doxorubicin—uterine cancer	0.000224	0.00114	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—BIRC5—uterine cancer	0.000224	0.00094	CbGpPWpGaD
Rifabutin—Body temperature increased—Epirubicin—uterine cancer	0.000224	0.00114	CcSEcCtD
Rifabutin—Abdominal pain—Epirubicin—uterine cancer	0.000224	0.00114	CcSEcCtD
Rifabutin—HSP90AA1—Disease—AKR1C1—uterine cancer	0.000222	0.00093	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—KRAS—uterine cancer	0.000218	0.000915	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—AKT1—uterine cancer	0.000217	0.000908	CbGpPWpGaD
Rifabutin—Feeling abnormal—Doxorubicin—uterine cancer	0.000216	0.0011	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—CXCL8—uterine cancer	0.000215	0.000901	CbGpPWpGaD
Rifabutin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000215	0.00109	CcSEcCtD
Rifabutin—HSP90B1—Immune System—CDH1—uterine cancer	0.000214	0.000899	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—CDKN1B—uterine cancer	0.00021	0.00088	CbGpPWpGaD
Rifabutin—Hypersensitivity—Epirubicin—uterine cancer	0.000209	0.00106	CcSEcCtD
Rifabutin—Body temperature increased—Doxorubicin—uterine cancer	0.000207	0.00106	CcSEcCtD
Rifabutin—Abdominal pain—Doxorubicin—uterine cancer	0.000207	0.00106	CcSEcCtD
Rifabutin—Asthenia—Epirubicin—uterine cancer	0.000203	0.00104	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—KRAS—uterine cancer	0.000203	0.000853	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—KRAS—uterine cancer	0.000201	0.000841	CbGpPWpGaD
Rifabutin—Pruritus—Epirubicin—uterine cancer	0.000201	0.00102	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—BIRC5—uterine cancer	0.000201	0.000841	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—PIK3CA—uterine cancer	0.000201	0.000841	CbGpPWpGaD
Rifabutin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000199	0.000834	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—POLD1—uterine cancer	0.000199	0.000832	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	0.000198	0.000829	CbGpPWpGaD
Rifabutin—Diarrhoea—Epirubicin—uterine cancer	0.000194	0.000988	CcSEcCtD
Rifabutin—Hypersensitivity—Doxorubicin—uterine cancer	0.000193	0.000985	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—FGFR2—uterine cancer	0.000193	0.000809	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—ERBB2—uterine cancer	0.000192	0.000807	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—DCN—uterine cancer	0.000192	0.000804	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RNF43—uterine cancer	0.000189	0.000791	CbGpPWpGaD
Rifabutin—Asthenia—Doxorubicin—uterine cancer	0.000188	0.000959	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—MET—uterine cancer	0.000188	0.000787	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—PIK3CA—uterine cancer	0.000187	0.000783	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	0.000186	0.000781	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AKR1C1—uterine cancer	0.000186	0.000779	CbGpPWpGaD
Rifabutin—Pruritus—Doxorubicin—uterine cancer	0.000186	0.000946	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—HRAS—uterine cancer	0.000186	0.000778	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—PIK3CA—uterine cancer	0.000184	0.000773	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—EP300—uterine cancer	0.000184	0.000773	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IRF1—uterine cancer	0.000184	0.000771	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	0.000184	0.00077	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—ERBB2—uterine cancer	0.000181	0.000758	CbGpPWpGaD
Rifabutin—Vomiting—Epirubicin—uterine cancer	0.00018	0.000919	CcSEcCtD
Rifabutin—Diarrhoea—Doxorubicin—uterine cancer	0.00018	0.000915	CcSEcCtD
Rifabutin—Rash—Epirubicin—uterine cancer	0.000179	0.000911	CcSEcCtD
Rifabutin—Dermatitis—Epirubicin—uterine cancer	0.000179	0.00091	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	0.000179	0.000749	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	0.000179	0.000749	CbGpPWpGaD
Rifabutin—Headache—Epirubicin—uterine cancer	0.000178	0.000905	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—VEGFA—uterine cancer	0.000175	0.000732	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.000174	0.000729	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	0.000173	0.000727	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—HRAS—uterine cancer	0.000173	0.000725	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—INHBA—uterine cancer	0.000172	0.000723	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—AKR1C3—uterine cancer	0.000171	0.000716	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—HRAS—uterine cancer	0.000171	0.000715	CbGpPWpGaD
Rifabutin—Nausea—Epirubicin—uterine cancer	0.000168	0.000858	CcSEcCtD
Rifabutin—HSP90B1—Immune System—CDKN1B—uterine cancer	0.000168	0.000702	CbGpPWpGaD
Rifabutin—Vomiting—Doxorubicin—uterine cancer	0.000167	0.00085	CcSEcCtD
Rifabutin—HSP90AA1—Disease—HMGA1—uterine cancer	0.000166	0.000697	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—RRM2—uterine cancer	0.000166	0.000694	CbGpPWpGaD
Rifabutin—Rash—Doxorubicin—uterine cancer	0.000165	0.000843	CcSEcCtD
Rifabutin—Dermatitis—Doxorubicin—uterine cancer	0.000165	0.000842	CcSEcCtD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000165	0.000693	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—FBXW7—uterine cancer	0.000165	0.000691	CbGpPWpGaD
Rifabutin—Headache—Doxorubicin—uterine cancer	0.000164	0.000837	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—AKT1—uterine cancer	0.000164	0.000687	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—DCN—uterine cancer	0.000161	0.000674	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CTNNB1—uterine cancer	0.000158	0.000663	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	0.000157	0.000658	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	0.000157	0.000658	CbGpPWpGaD
Rifabutin—Nausea—Doxorubicin—uterine cancer	0.000156	0.000794	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—AKR1C1—uterine cancer	0.000155	0.000651	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PTEN—uterine cancer	0.000154	0.000647	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	0.000153	0.00064	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—AKT1—uterine cancer	0.000153	0.00064	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—FBXW7—uterine cancer	0.000152	0.000638	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP11A1—uterine cancer	0.000151	0.000635	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—AKT1—uterine cancer	0.000151	0.000632	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN2A—uterine cancer	0.000149	0.000623	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	0.000149	0.000623	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—VEGFA—uterine cancer	0.000148	0.000621	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—EP300—uterine cancer	0.000147	0.000617	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	0.000147	0.000615	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—NRAS—uterine cancer	0.000146	0.000614	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	0.000144	0.000602	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AKR1C3—uterine cancer	0.000143	0.000599	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	0.000142	0.000594	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—NRAS—uterine cancer	0.000138	0.000577	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—ERBB2—uterine cancer	0.000137	0.000576	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	0.000137	0.000574	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	0.000135	0.000566	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—SOCS3—uterine cancer	0.000135	0.000566	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	0.000134	0.000561	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN2A—uterine cancer	0.000133	0.000557	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—TP53—uterine cancer	0.000132	0.000553	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN1B—uterine cancer	0.000132	0.000552	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	0.000126	0.00053	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—KRAS—uterine cancer	0.000126	0.000528	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—ERBB2—uterine cancer	0.000121	0.000508	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—CTNNB1—uterine cancer	0.00012	0.000504	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKR1C3—uterine cancer	0.00012	0.000501	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000119	0.000501	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000119	0.000501	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN2B—uterine cancer	0.000119	0.0005	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—KRAS—uterine cancer	0.000118	0.000497	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN1B—uterine cancer	0.000118	0.000493	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PGR—uterine cancer	0.000116	0.000488	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—EP300—uterine cancer	0.000116	0.000485	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—FGFR2—uterine cancer	0.000112	0.000471	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CDKN1B—uterine cancer	0.000112	0.000471	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EP300—uterine cancer	0.000112	0.000468	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—STK11—uterine cancer	0.000111	0.000467	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP19A1—uterine cancer	0.000111	0.000467	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—YWHAE—uterine cancer	0.000111	0.000466	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SMAD3—uterine cancer	0.000109	0.000456	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PIK3CA—uterine cancer	0.000109	0.000456	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	0.000107	0.00045	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—HRAS—uterine cancer	0.000107	0.000449	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FBXW7—uterine cancer	0.000107	0.000447	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CTNNB1—uterine cancer	0.000106	0.000445	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—VEGFA—uterine cancer	0.000106	0.000443	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	0.000106	0.000443	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—NRAS—uterine cancer	0.000104	0.000438	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	0.000104	0.000437	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—FGFR2—uterine cancer	0.000104	0.000435	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PTEN—uterine cancer	0.000103	0.000433	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—EP300—uterine cancer	0.000103	0.000433	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HRAS—uterine cancer	0.000101	0.000422	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MTHFR—uterine cancer	9.99e-05	0.000419	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EP300—uterine cancer	9.86e-05	0.000413	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—STK11—uterine cancer	9.31e-05	0.00039	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—NRAS—uterine cancer	9.22e-05	0.000387	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—KRAS—uterine cancer	8.99e-05	0.000377	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—AKT1—uterine cancer	8.89e-05	0.000373	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	8.77e-05	0.000368	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SOCS3—uterine cancer	8.72e-05	0.000366	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDH1—uterine cancer	8.37e-05	0.000351	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—MTHFR—uterine cancer	8.37e-05	0.000351	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN2B—uterine cancer	8.35e-05	0.00035	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IGF1R—uterine cancer	8.11e-05	0.00034	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—KRAS—uterine cancer	7.94e-05	0.000333	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—HRAS—uterine cancer	7.64e-05	0.00032	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SMAD3—uterine cancer	7.62e-05	0.00032	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—uterine cancer	7.4e-05	0.00031	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NDUFB11—uterine cancer	7.36e-05	0.000309	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SRD5A2—uterine cancer	7.36e-05	0.000309	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PIK3CA—uterine cancer	7.29e-05	0.000306	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FGFR2—uterine cancer	7.27e-05	0.000305	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.15e-05	0.0003	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ERBB2—uterine cancer	7.06e-05	0.000296	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.75e-05	0.000283	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—HRAS—uterine cancer	6.75e-05	0.000283	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—AKT1—uterine cancer	6.75e-05	0.000283	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDKN1B—uterine cancer	6.54e-05	0.000274	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ERBB2—uterine cancer	6.52e-05	0.000273	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ESR1—uterine cancer	6.22e-05	0.000261	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CTNNB1—uterine cancer	6.18e-05	0.000259	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN1B—uterine cancer	6.04e-05	0.000253	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PTEN—uterine cancer	6.02e-05	0.000252	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—AKT1—uterine cancer	5.96e-05	0.00025	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EP300—uterine cancer	5.74e-05	0.000241	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CTNNB1—uterine cancer	5.7e-05	0.000239	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SRD5A2—uterine cancer	5.68e-05	0.000238	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NDUFB11—uterine cancer	5.68e-05	0.000238	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTEN—uterine cancer	5.56e-05	0.000233	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCL2—uterine cancer	5.48e-05	0.00023	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NRAS—uterine cancer	5.37e-05	0.000225	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKR1B1—uterine cancer	5.32e-05	0.000223	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—STAR—uterine cancer	5.32e-05	0.000223	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EP300—uterine cancer	5.3e-05	0.000222	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.26e-05	0.000221	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NRAS—uterine cancer	4.96e-05	0.000208	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTEN—uterine cancer	4.66e-05	0.000195	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KRAS—uterine cancer	4.62e-05	0.000194	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ERBB2—uterine cancer	4.57e-05	0.000191	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—EP300—uterine cancer	4.44e-05	0.000186	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCL8—uterine cancer	4.33e-05	0.000182	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KRAS—uterine cancer	4.27e-05	0.000179	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CA—uterine cancer	4.25e-05	0.000178	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN1B—uterine cancer	4.23e-05	0.000177	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—POLD1—uterine cancer	4.18e-05	0.000175	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—STAR—uterine cancer	4.11e-05	0.000172	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKR1B1—uterine cancer	4.11e-05	0.000172	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CTNNB1—uterine cancer	3.99e-05	0.000167	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HRAS—uterine cancer	3.93e-05	0.000165	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CA—uterine cancer	3.92e-05	0.000164	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKR1C1—uterine cancer	3.91e-05	0.000164	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTEN—uterine cancer	3.89e-05	0.000163	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EP300—uterine cancer	3.71e-05	0.000156	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HRAS—uterine cancer	3.63e-05	0.000152	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—uterine cancer	3.52e-05	0.000147	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—RRM2—uterine cancer	3.48e-05	0.000146	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NRAS—uterine cancer	3.47e-05	0.000146	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—AKT1—uterine cancer	3.47e-05	0.000146	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—DCN—uterine cancer	3.38e-05	0.000142	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CA—uterine cancer	3.28e-05	0.000138	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—POLD1—uterine cancer	3.22e-05	0.000135	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—AKT1—uterine cancer	3.2e-05	0.000134	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP11A1—uterine cancer	3.18e-05	0.000134	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKR1C1—uterine cancer	3.01e-05	0.000126	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKR1C3—uterine cancer	3.01e-05	0.000126	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KRAS—uterine cancer	2.99e-05	0.000125	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CA—uterine cancer	2.75e-05	0.000115	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—RRM2—uterine cancer	2.69e-05	0.000113	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AKT1—uterine cancer	2.68e-05	0.000113	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—uterine cancer	2.66e-05	0.000111	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—DCN—uterine cancer	2.61e-05	0.000109	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HRAS—uterine cancer	2.54e-05	0.000107	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.46e-05	0.000103	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP19A1—uterine cancer	2.34e-05	9.82e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—STK11—uterine cancer	2.34e-05	9.82e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.32e-05	9.73e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKT1—uterine cancer	2.24e-05	9.41e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.2e-05	9.22e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.1e-05	8.79e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—STK11—uterine cancer	1.81e-05	7.58e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.81e-05	7.58e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MTHFR—uterine cancer	1.76e-05	7.38e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.55e-05	6.5e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MTHFR—uterine cancer	1.36e-05	5.7e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTEN—uterine cancer	9.79e-06	4.11e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—EP300—uterine cancer	9.34e-06	3.92e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTEN—uterine cancer	7.56e-06	3.17e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—EP300—uterine cancer	7.21e-06	3.02e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CA—uterine cancer	6.91e-06	2.9e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKT1—uterine cancer	5.64e-06	2.37e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CA—uterine cancer	5.33e-06	2.24e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKT1—uterine cancer	4.36e-06	1.83e-05	CbGpPWpGaD
